Glenn Phillips

4.5k total citations · 3 hit papers
78 papers, 3.2k citations indexed

About

Glenn Phillips is a scholar working on Pathology and Forensic Medicine, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Glenn Phillips has authored 78 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 20 papers in Neurology and 16 papers in Psychiatry and Mental health. Recurrent topics in Glenn Phillips's work include Multiple Sclerosis Research Studies (20 papers), Myasthenia Gravis and Thymoma (17 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). Glenn Phillips is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Myasthenia Gravis and Thymoma (17 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). Glenn Phillips collaborates with scholars based in United States, United Kingdom and Belgium. Glenn Phillips's co-authors include Richard A. Rudick, Nicholas G. LaRocca, Lynn D. Hudson, Ralph H. B. Benedict, John DeLuca, William R. Shadish, Ana Navarro, Georg E. Matt, Amanda S. Birnbaum and David M. Murray and has published in prestigious journals such as Psychological Bulletin, Neurology and Psychological Medicine.

In The Last Decade

Glenn Phillips

74 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis

2017 607 citations Ralph H. B. Benedict, Glenn Phillips et al. Multiple Sclerosis Journal profile →
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis

2017 344 citations Peter Feys, Ilse Lamers et al. Multiple Sclerosis Journal profile →
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis

2017 302 citations Robert W. Motl, Jeffrey A. Cohen et al. Multiple Sclerosis Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Glenn Phillips United States	26	1.5k	646	548	433	307	78	3.2k
Mark Agius United Kingdom	29	914 0.6×	983 1.5×	591 1.1×	403 0.9×	190 0.6×	237	3.3k
Deborah Miller United States	32	2.2k 1.5×	729 1.1×	753 1.4×	257 0.6×	333 1.1×	84	3.9k
Christopher Christodoulou United States	31	1.7k 1.2×	757 1.2×	863 1.6×	195 0.5×	169 0.6×	50	3.4k
Peter Joseph Jongen Netherlands	30	1.2k 0.8×	508 0.8×	702 1.3×	308 0.7×	138 0.4×	95	3.0k
Frederick W. Foley United States	25	2.2k 1.5×	433 0.7×	646 1.2×	280 0.6×	112 0.4×	103	2.9k
Jared M. Bruce United States	36	1.2k 0.8×	567 0.9×	472 0.9×	592 1.4×	474 1.5×	125	3.4k
Alessandra Solari Italy	43	2.7k 1.9×	1.0k 1.6×	1.1k 2.0×	320 0.7×	364 1.2×	148	5.6k
Marie D’hooghe Belgium	33	2.1k 1.4×	508 0.8×	620 1.1×	121 0.3×	168 0.5×	107	3.3k
Eli Silber United Kingdom	31	1.2k 0.8×	532 0.8×	278 0.5×	320 0.7×	710 2.3×	81	2.6k
Vincent de Groot Netherlands	30	1.2k 0.9×	552 0.9×	902 1.6×	178 0.4×	92 0.3×	121	2.8k

Countries citing papers authored by Glenn Phillips

Since Specialization

Citations

This map shows the geographic impact of Glenn Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Phillips more than expected).

Fields of papers citing papers by Glenn Phillips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Phillips. The network helps show where Glenn Phillips may publish in the future.

Co-authorship network of co-authors of Glenn Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Phillips. A scholar is included among the top collaborators of Glenn Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Phillips. Glenn Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dewilde, Sarah, Pierre Boulanger, R. C. Pardo, et al.. (2025). Caregiving burden among caregivers of people with myasthenia gravis. Orphanet Journal of Rare Diseases. 20(1). 311–311.

Dewilde, Sarah, et al.. (2025). A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severity. Frontiers in Public Health. 13. 1538789–1538789.

Dewilde, Sarah, Alison Griffiths, Cynthia Z. Qi, et al.. (2024). Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis. Journal of the Neurological Sciences. 466. 123264–123264. 7 indexed citations

Janssen, Mathieu F., Sarah Dewilde, Gil I. Wolfe, Srikanth Muppidi, & Glenn Phillips. (2024). Psychometric properties of MG-ADL items and MG-ADL score: An assessment of distributional characteristics, validity and factor structure in two large datasets. Journal of the Neurological Sciences. 463. 123135–123135.

Dewilde, Sarah, et al.. (2023). People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies. Advances in Therapy. 40(10). 4377–4394. 11 indexed citations

Dewilde, Sarah, Mathieu F. Janssen, Fiammetta Vanoli, et al.. (2023). Concordance between patient‐ and physician‐reported Myasthenia Gravis Activities of Daily Living (MG‐ADL) scores. Muscle & Nerve. 68(1). 65–72. 5 indexed citations

Phillips, Glenn, et al.. (2022). Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States. Frontiers in Neurology. 12. 809999–809999. 25 indexed citations

Schindler, David, Stephen M. Rao, James R. Williams, et al.. (2019). Multiple Sclerosis Performance Test: Technical Development and Usability. Advances in Therapy. 36(7). 1741–1755. 46 indexed citations

Matza, Louis S., et al.. (2019). Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS). Multiple Sclerosis and Related Disorders. 35. 253–261. 5 indexed citations

10.

Smith, Victoria M., et al.. (2018). Movement measurements at home for multiple sclerosis: walking speed measured by a novel ambient measurement system. Multiple Sclerosis Journal - Experimental Translational and Clinical. 4(1). 2452173433–2452173433. 13 indexed citations

11.

Feys, Peter, Ilse Lamers, Gordon Francis, et al.. (2017). The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis. Multiple Sclerosis Journal. 23(5). 711–720. 344 indexed citations breakdown →

12.

Motl, Robert W., Jeffrey A. Cohen, Ralph H. B. Benedict, et al.. (2017). Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. Multiple Sclerosis Journal. 23(5). 704–710. 302 indexed citations breakdown →

13.

Balcer, Laura J., Jenelle Raynowska, Rachel Nolan, et al.. (2017). Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis. Multiple Sclerosis Journal. 23(5). 734–747. 130 indexed citations

14.

Subramanian, Lakshminarayanan, et al.. (2016). Clinical improvements following bilateral anterior capsulotomy in treatment-resistant depression. Psychological Medicine. 47(6). 1097–1106. 23 indexed citations

15.

Phillips, Glenn, Shien Guo, Randall H. Bender, et al.. (2016). Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial. Multiple Sclerosis and Related Disorders. 6. 66–72. 17 indexed citations

16.

Vollmer, Timothy, Eva Havrdová, Krzysztof Selmaj, et al.. (2013). Daclizumab High-Yield Process Treatment Reduced the Impact of Multiple Sclerosis Relapse on Health-Related Quality of Life (Results of the SELECT Trial) (P03.212). Neurology. 80(7_supplement). 1 indexed citations

17.

Matza, Louis S., Kathleen W. Wyrwich, Glenn Phillips, et al.. (2012). The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition. Quality of Life Research. 22(2). 351–360. 14 indexed citations

18.

Ivanova, Jasmina, Howard G. Birnbaum, Lei Chen, et al.. (2011). Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance.. PubMed. 17(8). e314–23. 45 indexed citations

19.

Chen, Lei, Glenn Phillips, Joseph A. Johnston, et al.. (2011). The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial. BMC Psychiatry. 11(1). 203–203. 9 indexed citations

20.

Ascher‐Svanum, Haya, Allen W. Nyhuis, Virginia L. Stauffer, et al.. (2010). Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives. Current Medical Research and Opinion. 26(10). 2403–2410. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact